Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00212862
What this trial is testing

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

Who this might be right for
AnemiaCancer
Ortho Biotech Products, L.P. 2,130
Testing effectiveness (Phase 2)Study completedNCT00401544
What this trial is testing

Darbepoetin Alfa With or Without Intravenous (IV) Iron

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 243
Large-scale testing (Phase 3)Ended earlyNCT00210730
What this trial is testing

The Duration Study

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Large-scale testing (Phase 3)UnknownNCT00002926
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075030
What this trial is testing

AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Kind Pharmaceuticals LLC 36
Early research (Phase 1)Study completedNCT00080925
What this trial is testing

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
National Institutes of Health Clinical Center (CC) 20
Large-scale testing (Phase 3)Study completedNCT00002517
What this trial is testing

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00144495
What this trial is testing

Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Chugai Pharmaceutical 104
Large-scale testing (Phase 3)UnknownNCT05768997
What this trial is testing

High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia

Who this might be right for
Anemia
Hallym University Medical Center 312
Early research (Phase 1)Study completedNCT01213979
What this trial is testing

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-hematological Malignancies
Pharmacosmos A/S 16
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Testing effectiveness (Phase 2)Study completedNCT00239239
What this trial is testing

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Who this might be right for
Non-Myeloid MalignanciesAnemiaCancer
Amgen 44
Not applicableUnknownNCT02860598
What this trial is testing

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

Who this might be right for
AnemiaAcute Myeloid Leukemia
Hospices Civils de Lyon 104
Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Testing effectiveness (Phase 2)Ended earlyNCT00306267
What this trial is testing

PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

Who this might be right for
AnemiaCancerEpoetin Alfa
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 61
Large-scale testing (Phase 3)Study completedNCT00628043
What this trial is testing

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Who this might be right for
Anemia
Chugai Pharmaceutical 160
Post-approval studies (Phase 4)UnknownNCT02731378
What this trial is testing

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

Who this might be right for
Chemotherapy-induced Anaemia
Shanghai East Hospital 603
Large-scale testing (Phase 3)Study completedNCT02767765
What this trial is testing

Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Who this might be right for
Anemia
Hoffmann-La Roche 61
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Next Page